Year: 2024
Type: article
Abstract: Peptide drugs are experiencing a renaissance driven by technological breakthroughs and the success of recent blockbuster drugs. A versatile peptide chemistry toolbox, modern synthesis techniques, and powerful discovery platforms are addressing many inherent roadblocks in peptide drug discovery and development allowing complex diseases to be targeted with high specificity and efficacy. As we enter a new era, peptide drugs are well suited to pursue inherently challenging, underrepresented targets and provide innovative treatment options.
Author: Nathalie M. Grob
Institution: ETH Zurich
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4404730454
